.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The MANAS 1 AI model represents a significant leap in Indian neuro-diagnostics. Intellihealth developed the model, which interprets electrical activity from the brain to identify early signs of disease. Consequently, clinicians may soon utilize this technology to detect neurological conditions before they become clinically visible. This innovative tool aims to address the critical shortage of specialists in rural India.
The system utilizes over 60,000 hours of brainwave recordings from more than 25,000 patients. Furthermore, it boasts 400 million parameters to decode complex EEG signals that traditional imaging often misses. Dr. Puneet Agarwal emphasizes that this model acts as a basic language translator for the human brain. Therefore, it provides a robust foundation for developing disease-specific tools for conditions like epilepsy and dementia.
Public health experts highlight the immense potential for early access in community health centers. Since India faces a deficit of neurologists, this AI assists in preliminary screening and timely referrals. Moreover, early detection significantly reduces long-term disability costs for patients and the healthcare system. However, any specific diagnostic tool derived from this platform requires rigorous regulatory approval before clinical use. A next-generation version, MANAS 2, is expected in the coming weeks.
Q1: What is the primary purpose of MANAS 1?
MANAS 1 is a foundational AI model designed to interpret EEG signals for the early detection of neurological and psychiatric disorders, specifically addressing specialist shortages in India.
Q2: Who developed this AI platform?
The model was developed by Intellihealth (NeuroDx), led by neurologist Dr. Puneet Agarwal, with support from the Indian AI Mission under the Ministry of Electronics and Information Technology.
Q3: How does it differ from traditional tests like MRI?
Unlike an MRI, which visualizes structure, MANAS 1 interprets the electrical language of the brain to detect functional abnormalities before structural disease becomes visible.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
India unveils MANAS 1, a 400M parameter AI model trained on 60,000 hours of EEG data to enable early detection of neurological and psychiatric disorders....
5 months ago
Explore evidence-based tobacco cessation strategies tailored for low- and middle-income countries. Learn about the Ask-Advise-Connect model, WHO EML pharmacotherapy, and digital interventions to improve clinical outcomes.
Today
A multicenter MPOG database study of 289,047 cesarean delivery cases analyzed adherence to obstetric anesthesia best practices. General anesthesia avoidance reached 97.0%, while post-spinal vasopressor infusions (55.4%) and hypothermia prevention (56.7%) showed the lowest compliance, highlighting key targets.
Today
A landmark study analyzing over 56,000 adult health records in Delhi-NCR reveals that hypertension and diabetes coexistence affects nearly 5% of adults. The prevalence doubles expected rates and rises sharply after age 40. Early integrated screening is essential to prevent microvascular and macrovascular complications.
Today
Researchers developed a Haversian-inspired composite scaffold that addresses delayed vascularization and wet-state mechanical deterioration in critical bone defect repair. By integrating spatially programmed calcium phosphate minerals and selective silica reinforcement, the design promotes vascularized bone repair.
2 days back
A comprehensive observational analysis evaluates the impact of preoperative GLP-1 RA use on 14-day postoperative mortality, respiratory complications, and major adverse cardiovascular events compared to other antidiabetic therapies.
Today
